Evidence map›Paper›PMID 11470911›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Paradoxical intrathymic positive selection in mice with only a covalently presented agonist peptide.

C Viret, X He, C A Janeway

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C ViretSection of Immunobiology, Yale University School of Medicine, and Howard Hughes Medical Institute, New Haven, CT 06520-8011, USA.
X He
C A Janeway

Funding

INFLUENCE OF H-2 ANTIGENS ON T CELL RESPONSESR01AI014579 · NIAID · YALE UNIVERSITY · PI BOTTOMLY, KIM · 1985 to 2004
$1.9M
INFLUENCE OF H-2 ANTIGENS ON MOUSE T CELL RESPONSESR37AI014579 · NIAID · YALE UNIVERSITY · PI JANEWAY, CHARLES A · 1990 to 1999
–
NIAID NIH HHS AI-14579NIAID NIH HHS R01 AI014579NIAID NIH HHS R37 AI014579
6 · The paper itself

Abstract

The Y-Ae mAb and the 1H3.1 alphabeta T cell antigen receptor (TCR) are both specific for the I-Ealpha52-68 peptide bound to the I-A(b) major histocompatibility complex (MHC) class II molecule. Antigen-presenting cells (APCs) from I-A(b+) mice with a natural or transgenic (Tg) I-Ealpha chain activate mature 1H3.1 T cells and cause the deletion of 1H3.1 TCR Tg thymocytes. However, 1H3.1 T cells were neither activated nor inactivated by confrontation with APCs from I-Ab-Ep mice in which I-A(b) molecules are occupied only by the covalently associated Ealpha52-68 peptide. Instead, immature 1H3.1 TCR Tg thymocytes were efficiently positively selected into the CD4 lineage in the I-Ab-Ep thymus. This selection relied on specific recognition of the Ealpha52-68/I-A(b) complex because it was blocked by Y-Ae. 1H3.1 TCR Tg T cells maturing in the I-Ab-Ep thymus efficiently populated the periphery, displayed a naive phenotype, and were specifically reactive to the Ealpha52-68 peptide or to I-A(b+)I-Ealpha(+) APCs, indicating that 1H3.1 T cells were not antagonized in I-Ab-Ep mice. The data identify major histocompatibility complex class II molecules with only a covalently attached self-peptide as a ligand for in vivo positive selection of T cells specific for the same peptide.

Indexed as

AnimalsAnimals, NewbornAntibodies, MonoclonalAntigen-Presenting CellsMicePeptidesPhenotypeReceptors, Antigen, T-Cell, alpha-betaThymus GlandAntibodies, MonoclonalPeptidesReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID11470911
PMCPMC55405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.